SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-023497
Filing Date
2022-06-17
Accepted
2022-06-17 09:07:42
Documents
12
Period of Report
2022-06-16
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K lyra-8k_20220616.htm   iXBRL 8-K 44655
  Complete submission text file 0001564590-22-023497.txt   174002

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA lyra-20220616.xsd EX-101.SCH 5709
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE lyra-20220616_lab.xml EX-101.LAB 19410
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lyra-20220616_pre.xml EX-101.PRE 11591
6 EXTRACTED XBRL INSTANCE DOCUMENT lyra-8k_20220616_htm.xml XML 3542
Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617-373-4600
Lyra Therapeutics, Inc. (Filer) CIK: 0001327273 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39273 | Film No.: 221022533
SIC: 3841 Surgical & Medical Instruments & Apparatus